title: Refractory cystobiliary fistula secondary to percutaneous treatment of hydatid cyst: treatment with N-butyl 2-cyanoacrylate embolization.
abstract: A 27-year-old female with a type 2 hydatid cystic lesion in the liver according to the Gharbi classification (CE 3A according to the WHO classification) was referred for percutaneous treatment after albendazole treatment for 1 year. A catheterization technique was performed but hypertonic saline and alcohol were not given into the cavity due to cystobiliary leakage. During the 4-month follow-up period, sequential cavitography revealed biliary fistula, and bile-stained drainage had not been ceased despite the sphincterotomy, nasobiliary drainage catheter, and plastic stent. Since the patient refused to surgery, we embolized the biliary fistula using N-butyl 2-cyanoacrylate for the first time in the literature. At the 3-month follow-up, the patient's course was uneventful and ultrasound, multidetector-row CT, and MRI examinations revealed no collection in or adjacent to the cavity.
authors.affiliation: Department of Radiology, Ankara Ataturk Education and Research Hospital, Bilkent, 06800 Ankara, Turkey. mcanyigit@yahoo.com
authors.forename: Murat
authors.initials: M
authors.lastname: Canyigit
authors.forename: Mehmet
authors.initials: M
authors.lastname: Gumus
authors.forename: Nurdan
authors.initials: N
authors.lastname: Cay
authors.forename: Bekir
authors.initials: B
authors.lastname: Erol
authors.forename: Mustafa
authors.initials: M
authors.lastname: Karaoglanoglu
authors.forename: Okan
authors.initials: O
authors.lastname: Akhan
mesh_terms: D000328:Adult; D015766:Albendazole / Q000008:administration & dosage; D000923:Anticestodal Agents / Q000008:administration & dosage; D001658:Biliary Fistula / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D004322:Drainage; D004444:Echinococcosis, Hepatic / Q000175:diagnosis / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000379:methods*; D004659:Enbucrilate / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D014014:Tissue Adhesives / Q000008:administration & dosage*; D036542:Tomography, Spiral Computed; D014463:Ultrasonography
chemical_list: D000923:Anticestodal Agents; D014014:Tissue Adhesives; D015766:Albendazole; D004659:Enbucrilate